RP BIO INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,090 KRW | 0.00% |
|
-3.50% | +5.09% |
More news
| 1 week | -3.50% | ||
| Current month | -7.43% | ||
| 1 month | -9.55% | ||
| 3 months | +1.11% | ||
| 6 months | +17.44% | ||
| Current year | +5.09% |
1 week
8 960.00
9 400.00
1 month
8 960.0010 350.00
Current year
8 470.0010 400.00
1 year
7 190.0012 630.00
3 years
7 190.0020 700.00
5 years
7 190.0020 700.00
10 years
7 190.0020 700.00
| Managers | Title | Age | Since |
|---|---|---|---|
Nam-Ki Kim
CEO | Chief Executive Officer | 56 | - |
Jae-Hoon Yoon
CEO | Chief Executive Officer | 62 | - |
Yong-Tae Hwang
DFI | Director of Finance/CFO | 47 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jae-Hoon Yoon
CEO | Chief Executive Officer | 62 | - |
Sang-Hoon Park
BRD | Director/Board Member | 63 | - |
Nam-Ki Kim
CEO | Chief Executive Officer | 56 | - |
RP Bio lnc is a Korea-based company mainly engaged in the manufacture and sale of health functional foods and pharmaceuticals. The Company is engaged in the production and sale of health functional foods such as multi-vitamins, collagen, lactic acid bacteria, and aloe. In addition, the Company is engaged in the production and sale of medicines such as cold medicines, painkillers, dementia prevention medicines, acne treatment medicines, and sleep improvement medicines.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +5.09% | 57.23M | |
| +25.83% | 661B | |
| +26.60% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.75% | 231B | |
| +5.07% | 200B | |
| -8.92% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- A314140 Stock
